文献速递临床试验与 GCP

JUMPFOOD研究:水解胶原蛋白与维生素C联合运动治疗对运动员髌腱病(跳跃膝)的附加效果——双盲随机对照试验研究方案

The JUMPFOOD study: additional effect of hydrolyzed collagen and vitamin C to exercise treatment for patellar tendinopathy (jumper's knee) in athletes-study protocol for a double-blind randomized controlled trial.
PubMed 文献 · Trials · 2023-11-28

JUMPFOOD研究是一项双盲、两组随机对照试验,纳入76名16-40岁、髌腱病症状持续至少12周且每周至少运动一次的运动员,比较口服水解胶原蛋白/维生素C联合渐进性肌腱负荷练习(PTLE)与PTLE联合安慰剂对VISA-P评分(评估疼痛、功能、运动参与)的影响,主要终点为24周时VISA-P评分。所有参与者均接受教育、负荷管理建议及符合荷兰前膝痛指南的PTLE方案;干预组每日补充10 g水解胶原蛋白和40 mg维生素C共24周,对照组每日补充10 g麦芽糊精安慰剂。

要点

  • 研究纳入76名16-40岁、髌腱病症状持续至少12周的运动员,随机分为胶原蛋白/维生素C组与安慰剂组。
  • 所有参与者均接受教育、负荷管理建议及符合荷兰前膝痛指南的渐进性肌腱负荷练习。
  • 主要结局为24周时VISA-P评分,评估疼痛、功能和运动参与。

核心结论

  • JUMPFOOD研究是首个在髌腱病运动员中评估水解胶原蛋白/维生素C联合PTLE方案效果的大型随机对照试验。
  • 若胶原蛋白/维生素C补充显示有效,该治疗可应用于日常运动医学实践以改善髌腱病患者治疗结局。

研究设计与样本

  • 双盲、两组随机对照试验,计划纳入76名16-40岁、髌腱病症状持续至少12周且每周至少运动一次的运动员。
  • 所有参与者接受教育、负荷管理建议及符合荷兰前膝痛指南的PTLE方案;干预组每日补充10 g水解胶原蛋白和40 mg维生素C共24周,对照组每日补充10 g麦芽糊精安慰剂。
  • 测量在基线及12周和24周随访时进行;主要结局为VISA-P评分,次要结局包括功能测试时疼痛、柔韧性测量、血液采集、肌腱影像学特征和健康问卷。
  • 随访期间参与者通过数字周记记录运动参与、训练量、肌腱负荷、运动时疼痛、合并用药和副作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patellar tendinopathy (PT) is a common problem in jumping athletes. Management can be challenging and treatment outcome is not always successful. In combination with tendon loading exercises, hydrolyzed collagen/vitamin C supplementation appears to have a promising effect on the recovery of tendinopathy. The aim of this study is to evaluate whether the use of oral supplementation of hydrolyzed collagen and vitamin C in combination with progressive tendon loading exercises (PTLE) is superior to PTLE and placebo on VISA-P score (which rates pain, function, sports participation) after 24 weeks for athletes with PT. METHODS: The JUMPFOOD study is a double-blinded, two-armed randomized controlled trial, in which the effectiveness of oral supplementation of hydrolyzed collagen/vitamin C combined with PTLE compared to PTLE with placebo on pain and recovery of function in athletes with PT will be investigated. Seventy-six athletes aged 16-40 years, with symptoms of PT for at least 12 weeks, who play sports at least once a week will be included. All participants will receive education, advice with regard to load management and a PTLE program according to the Dutch guidelines for anterior knee pain. In addition, the intervention group will receive daily 10 g hydrolyzed collagen and 40 mg vitamin C supplementation for 24 weeks whereas the control group receives 10 g maltodextrin placebo supplementation. Measurements will take place at baseline and at 12 and 24 weeks' follow-up. Primary outcome is the VISA-P score, which evaluates pain, function, and sports participation. For secondary outcome measures, data with regard to pain during functional tests, flexibility measurements, blood withdrawals, imaging characteristics of the tendon, and health questionnaires will be collected. During the follow-up period, participants will register sports participation, amount of training and tendon load, pain during sports, co-medication, and side-effects in a digital weekly diary. DISCUSSION: The JUMPFOOD study is the first large RCT to study the effectiveness of hydrolyzed collagen/vitamin C supplementation in combination with the PTLE program in athletes with patellar tendinopathy. If supplementation of collagen/vitamin C appears to be effective, this treatment can be implemented in daily sports medicine practice to improve the treatment outcome of patients with PT. TRIAL REGISTRATION: ClinicalTrials.gov NCT05407194. Registered on 7 June 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van Dam L, Terink R, Mensink M, et al. The JUMPFOOD study: additional effect of hydrolyzed collagen and vitamin C to exercise treatment for patellar tendinopathy (jumper's knee) in athletes-study protocol for a double-blind randomized controlled trial. Trials. 2023. PMID: 38017500. doi:10.1186/s13063-023-07783-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。